Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Gram Negative Bacteremia
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

The investigators plan an open label randomized controlled trial to compare short-course antibiotic therapy (<=7 days) versus longer treatment (>7 days). The investigators will include hospitalized patients with gram-negative bacteremia. The investigators primary objective is to investigate the safety and efficacy of short-course antibiotics.

Provided treatments

  • Drug: short-course antibiotic treatment
  • Drug: accepted prolonged antibiotic treatment
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01737320. The sponsor of the trial is Rabin Medical Center and it is looking for 600 volunteers for the current phase.
Official trial title:
Duration of Antibiotics for the Treatment of Gram-negative Bacilli Bacteremia - a Randomized Controlled Trial